Hong Zhang

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 2

Top Topics

Drug Administration

Cardiovascular Risk Factors

Top Venues

Science advances

Evidence-based complementary and alternative medicine : eCAM

2nd Xiangya hospital of Central South University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

2nd Xiangya hospital of Central South University

China

M.D., Ph.D. :: Cardiovascular Surgery

Publications

Xi Guo, Xiaojun Chen, Jinlan Chen, Zhiping Tan, Yifeng Yang, Hong Zhang
Current Status and Evaluation of Randomized Clinical Trials of Traditional Chinese Medicine in the Treatment of Cardiovascular Diseases. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Xiao Ma, Ping Zhu, Yonghe Ding, Hong Zhang, Qi Qiu, Alexey V Dvornikov, Zheng Wang, Maengjo Kim, Yong Wang, Matthew R Lowerison, Yue Yu, Nadine Norton, Joerg Herrmann, Stephen C Ekker, Tzung K Hsiai, Xueying Lin, Xiaolei Xu
Retinoid X receptor alpha is a spatiotemporally predominant therapeutic target for anthracycline-induced cardiotoxicity. Science advances 6 (5) (2020)